Nutrition 21, Inc. (NXXI), a producer of a broad portfolio of nutritional supplements, reported fourth quarter 2008 financial results this morning. Revenues were $11.0 million, a 5% decrease year-over-year and a 2% increase sequentially. EBITDA of $0.8 million represents the first positive EBITDA quarter since Q2 2005. Net loss was $0.9 million, or 1 cent per diluted share, compared to a net loss of $8.2 million, or 13 cents per diluted share, for the same period a year ago. One analyst expected the company to report a loss of 7 cents per share on $11.1 million in revenues.